Challenges and innovation: Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes

Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) has both challenges and promise. While patient-derived iPSC-CMs provide a unique opportunity for disease modeling with isogenic cells, the challenge is that these cells still demonstrate distinct properties...

Descripción completa

Detalles Bibliográficos
Autores principales: Reilly, Louise, Munawar, Saba, Zhang, Jianhua, Crone, Wendy C., Eckhardt, Lee L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411865/
https://www.ncbi.nlm.nih.gov/pubmed/36035948
http://dx.doi.org/10.3389/fcvm.2022.966094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411865/
https://www.ncbi.nlm.nih.gov/pubmed/36035948
http://dx.doi.org/10.3389/fcvm.2022.966094

Ejemplares similares